Hypomelanosis of Ito

Incontinentia pigmenti achromians; HMI; Ito hypomelanosis

Definition

Hypomelanosis of Ito (HMI) is a very rare birth defect that causes unusual patches of light-colored (hypopigmented) skin and may be associated with eye, nervous system, and skeletal problems.

Causes

Health care providers do not know the exact cause of HMI, but they believe it may involve a genetic condition called mosaicism. It is twice as common in girls as in boys.

Symptoms

Skin symptoms are most often visible by the time a child is about 2 years old.

Other symptoms develop as the child grows, and may include:

Exams and Tests

Ultraviolet light (Wood lamp) examination of the skin lesions may help confirm the diagnosis.

Tests that may be done include any of the following:

  • CT or MRI scan of the head for a child with seizures and nervous system symptoms
  • X-rays for a child with skeletal problems
  • EEG to measure the electrical activity of the brain in a child with seizures
  • Genetic testing

Treatment

There is no treatment for the skin patches. Cosmetics or clothing may be used to cover the patches. Seizures, scoliosis, and other problems are treated as needed.

Outlook (Prognosis)

The outlook depends on the type and severity of symptoms that develop. In most cases, skin color eventually turns to normal.

Possible Complications

Problems that may result from HMI include:

  • Discomfort and walking problems due to scoliosis
  • Emotional distress, related to the physical appearance
  • Intellectual disability
  • Injury from seizures

When to Contact a Medical Professional

Contact your provider if your child has an unusual pattern of the color of the skin. However, any unusual patterns are likely to have another cause than HMI.

References

Joyce JC. Hypopigmented lesions. In: Kliegman RM, St. Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, eds. Nelson Textbook of Pediatrics. 21st ed. Philadelphia, PA: Elsevier; 2020:chap 672.

Patterson JW. Disorders of pigmentation. In: Patterson JW, ed. Weedon's Skin Pathology. 5th ed. Philadelphia, PA: Elsevier; 2021:chap 11.

Schedule An Appointment

Review Date: 5/31/2023

Reviewed By: Ramin Fathi, MD, FAAD, Director, Phoenix Surgical Dermatology Group, Phoenix, AZ. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.


View References

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language. © 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.